Lv51
1450 积分 2020-04-19 加入
CAR-T and TIL therapies in solid tumors: barriers, clinical lessons, and convergent solutions
2小时前
已完结
CAR Beyond αβ T Cells: Unleashing NK Cells, Macrophages, and γδ T Lymphocytes Against Solid Tumors
2小时前
已完结
Expanding Immunotherapy Beyond CAR T Cells: Engineering Diverse Immune Cells to Target Solid Tumors
2小时前
已完结
Barrier-matched, pharmacodynamic (PD)-gated immunotherapy development in MSS/pMMR colorectal cancer
2小时前
已完结
Engineering strategies to address immune and delivery barriers in pancreatic ductal adenocarcinoma: a barrier-matched translational framework
2小时前
已完结
CAR-M Therapy: From Concept to Clinical Translation in Solid Tumors
2小时前
已完结
Different Immune Cells Modified With Chimeric Antigen Receptors Are Being Applied to Ovarian Cancer: Which Is the Most Effective?
2小时前
已完结
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
2小时前
已完结
Beyond CAR-T Cells: exploring CAR-NK, CAR-M, and CAR-γδ T strategies in solid tumor immunotherapy
2小时前
已完结
Targeting metabolic reprogramming to enhance adoptive immunotherapy: emerging mechanisms and translational perspectives
2小时前
已完结
皖公网安备34019202002308
